Drug General Information (ID: DDIP0K67CJ)
  Drug Name Sulfacetamide (ophthalmic) Drug Info Silver nitrate (ophthalmic) Drug Info
  Drug Type Small molecule Small molecule
  Therapeutic Class Antibiotics Antiseptic/Germicides
  Structure

 Mechanism of Sulfacetamide (ophthalmic)-Silver nitrate (ophthalmic) Interaction (Severity Level: Moderate)
     Attenuated pharmacological effects (Unspecific) Click to Show/Hide Mechanism Graph
      Drug Name Sulfacetamide (ophthalmic) Silver nitrate (ophthalmic)
      Mechanism Combination of silver agents form precipitates Silver agents
      Key Mechanism Factor 1
Factor Name Pharmacodynamics
Factor Description Reduced pharmacological effects leading to insufficient efficacy and/or treatment failure.
      Mechanism Description
  • Attenuated pharmacological effects of  Sulfacetamide (ophthalmic) when combined with Silver nitrate (ophthalmic) 

Recommended Action
      Management Concurrent use of sulfacetamide preparations with silver preparations should be avoided.

References
1 Product Information. FML-S Liquifilm Sterile Ophthalmic Suspension (fluorometholone-sodium sulfacetamide ophthalmic). Allergan Inc, Irvine, CA.